Sodium-glucose transport protein 2 inhibitors (SGLT2i) are becoming commonplace in many chronic diseases: type 2 diabetes mellitus, heart failure, and chronic kidney disease. We present the case of a 65-year-old male with a history of type 2 diabetes who had been on an SGLT2i for over 12 months and was found to have euglycemic diabetic ketoacidosis (eDKA) occurring concurrently with a thyroid storm. This case report illustrates a unique scenario of two endocrine emergencies occurring simultaneously.
Keywords: critical care and hospital medicine; endocrine emergencies; euglycemic diabetoketoacidosis; gluconeogenesis; sglt-2 inhibitor; thyroid-storm.
Copyright © 2024, Strawn et al.